286 related articles for article (PubMed ID: 33509668)
1. Role of polyunsaturated fatty acids in ischemic stroke - A perspective of specialized pro-resolving mediators.
Miao Z; Schultzberg M; Wang X; Zhao Y
Clin Nutr; 2021 May; 40(5):2974-2987. PubMed ID: 33509668
[TBL] [Abstract][Full Text] [Related]
2. Specialized pro-resolving mediators: biosynthesis and biological role in bacterial infections.
Jordan PM; Werz O
FEBS J; 2022 Jul; 289(14):4212-4227. PubMed ID: 34741578
[TBL] [Abstract][Full Text] [Related]
3. Pro-Resolving Lipid Mediators in the Pathophysiology of Asthma.
Kytikova O; Novgorodtseva T; Denisenko Y; Antonyuk M; Gvozdenko T
Medicina (Kaunas); 2019 Jun; 55(6):. PubMed ID: 31216723
[TBL] [Abstract][Full Text] [Related]
4. Polyunsaturated Fatty Acids: Conversion to Lipid Mediators, Roles in Inflammatory Diseases and Dietary Sources.
Harwood JL
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240183
[TBL] [Abstract][Full Text] [Related]
5. Lipid mediators and sterile inflammation in ischemic stroke.
Nakamura A; Otani K; Shichita T
Int Immunol; 2020 Oct; 32(11):719-725. PubMed ID: 32300780
[TBL] [Abstract][Full Text] [Related]
6. Polyunsaturated fatty acids, specialized pro-resolving mediators, and targeting inflammation resolution in the age of precision nutrition.
Al-Shaer AE; Buddenbaum N; Shaikh SR
Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Jul; 1866(7):158936. PubMed ID: 33794384
[TBL] [Abstract][Full Text] [Related]
7. Specialized Pro-Resolving Mediators in Neuroinflammation: Overview of Studies and Perspectives of Clinical Applications.
Valente M; Dentoni M; Bellizzi F; Kuris F; Gigli GL
Molecules; 2022 Jul; 27(15):. PubMed ID: 35956787
[TBL] [Abstract][Full Text] [Related]
8. Molecular Pharmacology of Inflammation Resolution in Atherosclerosis.
Kotlyarov S; Kotlyarova A
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563200
[TBL] [Abstract][Full Text] [Related]
9. The role of omega-3 polyunsaturated fatty acids in the intensive care unit.
Singer P; Calder PC
Curr Opin Clin Nutr Metab Care; 2023 Mar; 26(2):129-137. PubMed ID: 36892961
[TBL] [Abstract][Full Text] [Related]
10. The Role of Specialized Pro-Resolving Lipid Mediators in Inflammation-Induced Carcinogenesis.
Torres W; Pérez JL; Díaz MP; D'Marco L; Checa-Ros A; Carrasquero R; Angarita L; Gómez Y; Chacín M; Ramírez P; Villasmil N; Durán-Agüero S; Cano C; Bermúdez V
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628804
[TBL] [Abstract][Full Text] [Related]
11. Specialized Pro-Resolving Lipid Mediators: The Future of Chronic Pain Therapy?
Chávez-Castillo M; Ortega Á; Cudris-Torres L; Duran P; Rojas M; Manzano A; Garrido B; Salazar J; Silva A; Rojas-Gomez DM; De Sanctis JB; Bermúdez V
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638711
[TBL] [Abstract][Full Text] [Related]
12. [Anti-inflammatory pro-resolving derivatives of omega-3 and omega-6 polyunsaturated fatty acids].
Nowak JZ
Postepy Hig Med Dosw (Online); 2010 Mar; 64():115-32. PubMed ID: 20354260
[TBL] [Abstract][Full Text] [Related]
13. Chronic Inflammation in PCOS: The Potential Benefits of Specialized Pro-Resolving Lipid Mediators (SPMs) in the Improvement of the Resolutive Response.
Regidor PA; Mueller A; Sailer M; Gonzalez Santos F; Rizo JM; Egea FM
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396555
[TBL] [Abstract][Full Text] [Related]
14. Specialized Pro-Resolving Lipid Mediators in Neonatal Cardiovascular Physiology and Diseases.
Gila-Diaz A; Carrillo GH; Singh P; Ramiro-Cortijo D
Antioxidants (Basel); 2021 Jun; 10(6):. PubMed ID: 34201378
[TBL] [Abstract][Full Text] [Related]
15. Specialized Pro-Resolving Lipid Mediators: Endogenous Roles and Pharmacological Activities in Infections.
Rasquel-Oliveira FS; Silva MDVD; Martelossi-Cebinelli G; Fattori V; Casagrande R; Verri WA
Molecules; 2023 Jun; 28(13):. PubMed ID: 37446699
[TBL] [Abstract][Full Text] [Related]
16. N-3 Polyunsaturated Fatty Acids and the Resolution of Neuroinflammation.
Joffre C; Rey C; Layé S
Front Pharmacol; 2019; 10():1022. PubMed ID: 31607902
[TBL] [Abstract][Full Text] [Related]
17. Regulation of T-Cell Immune Responses by Pro-Resolving Lipid Mediators.
Perez-Hernandez J; Chiurchiù V; Perruche S; You S
Front Immunol; 2021; 12():768133. PubMed ID: 34868025
[TBL] [Abstract][Full Text] [Related]
18. Specialized Pro-Resolving Lipid Mediators: Emerging Therapeutic Candidates for Multiple Sclerosis.
Zahoor I; Giri S
Clin Rev Allergy Immunol; 2021 Apr; 60(2):147-163. PubMed ID: 32495237
[TBL] [Abstract][Full Text] [Related]
19. Actors and Factors in the Resolution of Intestinal Inflammation: Lipid Mediators As a New Approach to Therapy in Inflammatory Bowel Diseases.
Ungaro F; Rubbino F; Danese S; D'Alessio S
Front Immunol; 2017; 8():1331. PubMed ID: 29109724
[TBL] [Abstract][Full Text] [Related]
20. Roles of Specialized Pro-Resolving Lipid Mediators in Cerebral Ischemia Reperfusion Injury.
Yin P; Wei Y; Wang X; Zhu M; Feng J
Front Neurol; 2018; 9():617. PubMed ID: 30131754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
